A few years ago. This is an Interesting Data play that s. A. P. Made here. Qualtrix youre able to ask questions in your organization, collect some of that hard to get data and use it to improve processes. Dell seems to be looking to do the opposite but it says something about the way that the Big Enterprises are thinking about their assets this is one of the busier weeks i can remember, the back to back. And it will be huz i think one of the Big Questions is it sustainable. Are we going to continue to see that continue. We saw with netfli and that a lot of future Revenue Growth was pulled forward even if microsoft you said the cloud was not quite perfect. Question, a surge, but it was not as good as it has been investors were a little punishing towards that it may set the stage, and in the meantime amazon really leading the way up 65 year to date with a number of price target hikes this morning how high can they go, right, carl we were just having that discussion with john chambers. An
Welcome back. If you can please take your seats. Looking forward to the next panel around some of the clinical advances that have been made over the past 50 years by virtue of the National Cancer act. You know, as a former nci director, you know that one of your greatest assets and some of your best friends are those heroes who agree to become Cancer Center directors, because they have to deal with the complexity of everything from supporting basic research on one end of the spectrum to all the way to the other end of the spectrum with regard to training, clinical research, cancer prevention, et cetera. Being a director is a challenge. Were very fortunate today to have with us to chair this next panel dr. Steve rosen who was the for 24 years the director of the robert h lauri and is the head of the Beckman Research center at city of hope. He has a distinguished career as a medical oncologist and particularly addressing himself now to much of the academic progress thats being made, havi
Welcome back. If you can please take your seats. Looking forward to the next panel around some of the clinical advances that have been made over the past 50 years by virtue of the National Cancer act. You know, as a former nci director, you know that one of your greatest assets and some of your best friends are those heroes who agree to become Cancer Center directors, because they have to deal with the complexity of everything from supporting basic research on one end of the spectrum to all the way to the other end of the spectrum with regard to training, clinical research, cancer prevention, et cetera. Being a director is a challenge. Were very fortunate today to have with us to chair this next panel dr. Steve rosen who was the for 24 years the director of the robert h lauri and is the head of the Beckman Research center at city of hope. He has a distinguished career as a medical oncologist and particularly addressing himself now to much of the academic progress thats being made, havi
Welcome back. If you can please take your seats. Looking forward to the next panel around some of the clinical advances that have been made over the past 50 years by virtue of the National Cancer act. You know, as a former nci director, you know that one of your greatest assets and some of your best friends are those heroes who agree to become Cancer Center directors, because they have to deal with the complexity of everything from supporting basic research on one end of the spectrum to all the way to the other end of the spectrum with regard to training, clinical research, cancer prevention, et cetera. Being a director is a challenge. Were very fortunate today to have with us to chair this next panel dr. Steve rosen who was the for 24 years the director of the robert h lauri and is the head of the Beckman Research center at city of hope. He has a distinguished career as a medical oncologist and particularly addressing himself now to much of the academic progress thats being made, havi